SCHEMBL19984493

SCHEMBL19984493

O=C(O)c1ccc2c(c1)NC(=O)c1ccncc1S2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 1/20 0.49
HTT P42858 1/20 0.46
TP53 P04637 6/20 0.45
MAPT P10636 5/20 0.45
SMN1; SMN2 Q16637 4/20 0.45
RXFP1 Q9HBX9 2/20 0.45
POLB P06746 4/20 0.44
L3MBTL1 Q9Y468 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43
PARP1 P09874 1/20 0.42
CSNK2A1 P68400 1/20 0.42
TLK2 Q86UE8 1/20 0.40
GAA P10253 2/20 0.40
NOX1 Q9Y5S8 2/20 0.40
MEN1 O00255 1/20 0.40
CYBB P04839 1/20 0.40
APP P05067 1/20 0.40
ALOX15 P16050 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23094972 0.84 HPGD (0.55) HPGDHTTTP53MAPTSMN1; SMN2
SCHEMBL4670438 0.81 HPGD (0.70) HPGDHTTTP53MAPTSMN1; SMN2
SCHEMBL29441686 0.79 HPGD (0.51) HPGDHTTTP53MAPTSMN1; SMN2
SCHEMBL17085845 0.79 HPGD (0.51) HPGDHTTTP53MAPTSMN1; SMN2
SCHEMBL17086128 0.78 TP53 (0.57) HPGDHTTTP53MAPTSMN1; SMN2
SCHEMBL5062829 0.78 TP53 (0.57) HPGDHTTTP53MAPTSMN1; SMN2
SCHEMBL5064794 0.78 HPGD (0.50) HPGDHTTTP53MAPTSMN1; SMN2
SCHEMBL19984495 0.77 TLK2 (0.40) HTTSMN1; SMN2POLBPARP1CSNK2A1
SCHEMBL28481360 0.77 NOX1 (0.60) HPGDHTTTP53MAPTSMN1; SMN2
SCHEMBL5057271 0.76 TP53 (0.58) HPGDHTTTP53MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2022-01-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-10987360-B2 Hepatitis B core protein modulators ASSEMBLY BIOSCIENCES, INC. (US) 2021-04-27 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES INC (US) 2019-08-22 US disclosed
WO-2018053157-A1 HEPATITIS B CORE PROTEIN MODULATORS ASSEMBLY BIOSCIENCES, INC. (US) 2018-03-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10987360-B2 Hepatitis B core protein modulators HAVCR2, FABP1, MAVS HPGD 2902/4885HTT 4564/4885TP53 724/4885
US-20190255067-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS HPGD 2902/4885HTT 4564/4885TP53 724/4885
US-20220023311-A1 HEPATITIS B CORE PROTEIN MODULATORS HAVCR2, FABP1, MAVS HPGD 2902/4885HTT 4564/4885TP53 724/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.